Rybelsus®

Semaglutide

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.
more
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
BGN 28.58
BGN 2572.60BGN 28.58
BGN 342.84
60 tablet
Free AirMail shipping Hot
BGN 30.49
BGN 1829.38BGN 30.49
BGN 114.25
30 tablet
Free AirMail shipping Hot
BGN 32.39
BGN 971.81BGN 32.39
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
BGN 34.30
BGN 3087.14BGN 34.30
BGN 171.32
60 tablet
Free AirMail shipping Hot
BGN 35.25
BGN 2115.23BGN 35.25
BGN 57.08
30 tablet
Free AirMail shipping Hot
BGN 36.21
BGN 1086.15BGN 36.21
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
BGN 40.97
BGN 3687.43BGN 40.97
BGN 171.32
60 tablet
Free AirMail shipping Hot
BGN 41.92
BGN 2515.43BGN 41.92
BGN 57.08
30 tablet
Free AirMail shipping Hot
BGN 42.88
BGN 1286.25BGN 42.88
Rybelsus

Brand(s)

Manufacturer

  • Novo Nordisc India Pvt. Ltd

Disease(s)

  • Type 2 Diabetes Mellitus / High Blood Sugar

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.